Compare MIRM & DORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRM | DORM |
|---|---|---|
| Founded | 2018 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2019 | 1991 |
| Metric | MIRM | DORM |
|---|---|---|
| Price | $79.34 | $123.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $92.45 | ★ $180.50 |
| AVG Volume (30 Days) | ★ 809.5K | 182.2K |
| Earning Date | 11-04-2025 | 10-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.49 |
| EPS | N/A | ★ 8.03 |
| Revenue | $471,794,000.00 | ★ $2,126,159,000.00 |
| Revenue This Year | $53.78 | $9.99 |
| Revenue Next Year | $19.91 | $5.25 |
| P/E Ratio | ★ N/A | $15.64 |
| Revenue Growth | ★ 53.66 | 7.94 |
| 52 Week Low | $36.88 | $106.95 |
| 52 Week High | $82.58 | $166.89 |
| Indicator | MIRM | DORM |
|---|---|---|
| Relative Strength Index (RSI) | 62.33 | 36.02 |
| Support Level | $77.99 | $124.38 |
| Resistance Level | $82.58 | $128.88 |
| Average True Range (ATR) | 3.21 | 2.77 |
| MACD | 1.03 | 0.22 |
| Stochastic Oscillator | 83.25 | 6.52 |
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.